|
|
|
|
|
| Congratulations to ResNovas on their AbbVie Golden Ticket
We are excited to see the progress you have made in tackling highly validated but historically undruggable targets in oncology and beyond!
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
|
|
MBC BioLabs expands its partnerships and is excited to welcome ACROBiosystems, Withum, and DeepCell to our community |
|
|
|
|
|
Leica Spatial Biology Symposium
Explore the latest advancements in spatial biology, featuring cutting-edge technologies and research. Learn how spatial mapping is unlocking molecular insights across oncology, neurology, and immunology.
May 6 @ 10am - 5pm
1030 Brittan Ave, San Carlos
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
ACROBiosystems launches its partnership with MBC BioLabs
We are delighted to welcome ACROBiosystems as our latest partner who is joining us to support our community of life sciences startups. We invite you to join us for two introductory lunches and learn about the exciting product and service offerings from ACROBiosystems.
Learn more about this exciting partnership here, and don’t miss our partnership launch events! |
|
|
|
|
|
|
|
|
|
|
|
|
May 7 @ noon - 1pm
135 Mississippi St, San Francisco
REGISTER ► |
|
|
| May 8 @ noon - 1pm
1030 Brittan Ave, San Carlos
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
Revvity Solutions Genomics Symposium
Join researchers from biotech, pharma, and academia for discussions on emerging genomics technologies and applications. Featuring a keynote by Dr. Jimmy Ye on innovation in translational genomics and proteomics.
May 13 @ noon - 4pm
135 Mississippi St, San Francisco
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
Promega Instrument Showcase
Join our friends at Promega who are hosting an instrument Showcase featuring hands-on demos of automation and assay technologies—including Maxwell RSC, MyGlo, and GloMax Discover—along with training, partner connections, and light refreshments. |
|
|
|
|
|
|
|
|
|
|
|
|
May 19 @ 12pm - 2pm
1030 Brittan Ave, San Carlos
REGISTER ► |
|
|
| May 20 @ 10am - 12pm
135 Mississippi St, San Francisco
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
Join us as we welcome Withum to the MBC BioLabs Ecosystem of Partners |
|
|
|
|
|
|
|
|
|
|
|
|
May 21 @ noon - 1pm
135 Mississippi St, San Francisco
REGISTER ► |
|
|
| May 28 @ noon - 1pm
1030 Brittan Ave, San Carlos
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Synthetic Design Lab emerges from stealth with a vision for smarter cancer drugs
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
|
| Cartography advances key oncology milestone through expanded collaboration with Gilead
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| May 6 @ 5pm - 8pm
San Carlos
A candid gathering for biotech founders and operators navigating the people side of building startups. Discuss hiring, trust, conflict, and communication in fast-moving, high-stakes environments.
REGISTER ► |
|
|
| | AI x Health | Women in AI
May 12 @ 6pm - 8pm
San Francisco
Explore how AI is transforming healthcare, biotech, and clinical innovation. Connect with leaders at the intersection of technology and life sciences.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
| Biocom CEO/Founder Network
May 14 @ 5pm - 7:30pm
135 Mississippi St, San Francisco
A candid VC panel on how investors evaluate platform, single-asset, and multi-asset/pipeline strategies in today’s competitive and capital‑constrained biotech market—and what it takes to meet Series A expectations.
REGISTER ► |
|
|
| | Founders at Work: EBVio
May 15 @ noon - 1pm
930 Brittan Ave, San Carlos
Guy Cavet is co-founder of EBVio, Prompt Therapeutics, and Flatiron Bio, and previously co-founded other companies including Atreca (BCEL). He will discuss his experiences as a founder, including scientific highlights and lessons learned.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
| Twist Bio & Women in Bio Event
May 19 @ 5:30pm - 8:30pm
1030 Brittan Ave, San Carlos
A community-driven event highlighting leadership, innovation, and inclusion in biotech. Network with professionals and advocates supporting women in the life sciences.
REGISTER ► |
|
|
| | Morrison Foerster Biotech Research Tools & Diagnostics Pitch Day
May 20 @ 4:30pm - 7:30pm
135 Mississippi St, San Francisco
This event is a great opportunity to get a first look at what’s next in the space and connect with founders, investors, and industry leaders across the Bay Area biotech ecosystem.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
| RAPS SF Executive Roundtable: AI & Portfolio Prioritization
May 21 @ 4pm - 8pm
San Carlos
An exclusive VP+ roundtable on implementing AI responsibly and making strategic portfolio decisions. Engage with industry leaders in a facilitated discussion on innovation and investment discipline.
REGISTER ► |
|
|
| | AI and the Future of Drug Discovery
May 26 @ 5pm - 7:30pm
San Carlos
Explore how cutting-edge AI models are transforming drug discovery, from early research to real-world therapeutics. Join experts for insights on translating innovation into clinical impact.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
|
| MBC BioLabs Nucleic Acid Medicine Innovation Forum
May 27 @ 3pm - 7:30pm
1030 Brittan Ave, San Carlos
A focused forum on advances in nucleic acid medicine and emerging biotech innovations. Hear from experts and connect with the ecosystem driving next-gen therapeutics.
REGISTER ► |
|
|
| |
|
|
|
|
|
|
|
|
|
|
MEET OUR NEWEST RESIDENTS |
|
|
|
|
Cerepeut develops oral small molecule therapeutics that reduce oxidative stress and restore cellular energy balance by targeting mitochondrial biology.
Founded by professors from Stanford and UCSF, the company focuses on two major indications: functional aging, including frailty and sarcopenia, and neurodegeneration. Its lead program, CP-235, is advancing toward clinical development this year, with the goal of addressing core biological drivers of age-related decline rather than individual symptoms. |
|
|
|
QCellect is building a next-generation QC platform for genetic medicines, using nanopore sequencing and custom analytics to replace fragmented legacy assays. By providing deeper molecular insights into product identity and purity, the company helps developers navigate regulatory pressures and accelerate therapies toward the clinic.
While initially focusing on AAV and viral vector process development, QCellect has significant expansion potential into RNA therapeutics and data-driven recurring revenue models. As advanced therapy pipelines grow more complex, QCellect is positioned to become the essential "quality layer" infrastructure for the genetic medicine industry. |
|
|
|
Post Translational Medicines (PTM) is pioneering a new paradigm in drug discovery by systematically targeting the dynamic regulatory layer of biology that exists beyond the genome and proteome: the Dark Proteome. Rather than focusing solely on protein abundance or genetic mutation, PTM is building an in cellulo proteome-wide "motion tracking" platform that maps, interprets, and therapeutically modulates proteoforms at scale. By integrating advanced proteomics, computational modeling, and small molecule discovery, PTM aims to unlock a vast and largely untapped space of druggable biology—enabling the development of first-in-class therapies for age-related and chronic diseases where protein dysregulation, rather than genetic alteration, is the primary driver. |
|
|
|
Welcome Synthetic Design Lab out of stealth mode. Synthetic Design Lab is a next-generation antibody-drug conjugate (ADC) company building the future of biologics on new foundations, with a focus on bringing new therapies to those affected by difficult-to-treat cancers. |
|
|
|
|
|
|
